Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Giles Mark T Create: Alert

All | News | Filings
Date FiledTypeDescription
08/06/2019 4/A Giles Mark T (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns: Granted 19,200 options to buy @ $3.15, valued at $60.5k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy